Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Cigarette smoking rates in the American population are approximately 23%, whereas rates of smoking in clinical and population studies of individuals with neuropsychiatric disorders are typically two- to four-fold higher. Studies conducted in a variety of neuropsychiatric populations [e.g. attention-deficit hyperactivity disorder (ADHD), Alzheimer's disease, schizophrenia] have collectively suggested that nicotine may be efficacious in remediating selected cognitive deficits associated with these disorders, thus providing a framework for understanding the specific vulnerability of these patients to smoking initiation and maintenance. However, the specific gain in cognitive performance produced by nicotine administration in healthy subjects with normal cognitive function is less clear. This article reviews our current understanding of central nicotinic acetylcholine receptor (nAChRs) systems in normal and neuropsychiatric disease states and, specifically, their role with respect to cognitive dysfunction and clinical symptoms in several specific neuropsychiatric populations, including ADHD, Alzheimer's disease, Parkinson's disease, Tourette's Disorder, schizophrenia and affective disorders. The potential benefits of nicotinic agents for therapeutic use in neuropsychiatric disorders is discussed, as well as directions for further research in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356 · cited 1×
“…initiation of smoking, genetic liability accounted for 50% of the variance in risk of becoming a regular smoker (Tsuang et al., 2001), whereas a meta-analysis of genetic and environmental influences on liability to schizophrenia by Sullivan et al. (2003) estimated high heritability (81%).”
Kendler, K. S., Prescott, C. A., Myers, J., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.929 · Cited by 1,868
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.279 · Cited by 1,199
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · cited 1×
“These deficits in P50 gating are closely linked to the α7 receptor locus on chromosome 15q14 (Freedman et al., 1997).”
Smoking and Major Depression: A Causal Analysis
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130038007 · Cited by 792
Schizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
Nicotine dependence, major depression, and anxiety in young adults
Breslau, N. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360033005 · Cited by 634
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415
Research works printed but not linked: 165
- AciernoR A, KilpatrickD G, ResnickH S, SaundersB E, BestC L (1996) Violent assault, posttraumatic stress disorder, and depression. Risk factors for cigarette use among adult women. Behav Modificat 20: 363-384 · DOI
- 10.1176/ajp.150.12.1856 · DOI · Paper page
- 10.2165/00002512-199711060-00004 · DOI
- 10.1038/sj.npp.1300265 · DOI
- 10.1016/S0166-2236(00)01716-1 · DOI · Paper page
- 10.1016/0091-3057(85)90139-X · DOI · Paper page
- 10.1212/WNL.30.8.839 · DOI
- 10.1080/02791072.1999.10471731 · DOI
- Beckham J C, 1995, Addict Behav, 20, 1, 10.1016/0306-4603(94)00037-Y · DOI
- 10.1002/jts.2490080308 · DOI
- 10.1016/S0306-4603(96)00071-8 · DOI · Paper page
- 10.1016/0304-3940(92)90179-B · DOI
- BosboomJ L, StoffersD, WoltersECh (2003) The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease. J Neural Transm 65 (Suppl): 185-195 · DOI
- Breese C R, 1997, J Pharmacol Exp Ther, 282, 7, 10.1016/S0022-3565(24)36798-9 · DOI · Paper page
- 10.1016/S0893-133X(00)00121-4 · DOI · Paper page
- 10.1212/WNL.43.2.293 · DOI · Paper page
- 10.1001/archpsyc.56.12.1141 · DOI · Paper page
- 10.1016/S1353-8020(03)00028-2 · DOI
- 10.1007/BF02245195 · DOI
- Conners C K, 1996, Psychopharmacol Bull, 32, 67
- 10.1192/bjp.179.1.35 · DOI
- 10.1016/S0006-3223(00)01116-1 · DOI · Paper page
- CoyleJ, KershawP (2001) Galanthamine, a Cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. Biol Psychiatry 49: 289-299 · DOI · Paper page
- 10.1176/ajp.155.11.1490 · DOI · Paper page
- 10.1080/14622200210141635 · DOI
- Delagarza V W, 2003, Am Family Phys, 68, 1365
- 10.1007/s002130050631 · DOI
- 10.1177/026988119901300106 · DOI
- DepatieL, DriscollG A, HolahanA-L. V, AtkinsonV, ThavundayilJ X, Ying KinN N, SamarthjiL (2002) Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Ncuropsychopharmacology 27: 1056-1070 · DOI · Paper page
- Donnelly Roberts D L, 1998, J Pharmacol Exp Ther, 285, 777, 10.1016/S0022-3565(24)37422-1 · DOI
- 10.1007/s002130100719 · DOI
- 10.1017/S0033291796003984 · DOI
- 10.1124/mol.64.6.1283 · DOI
- 10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F · doi:10.1002/1531-8257(199911)14:6<1011::aid-mds1016>3.0.co;2-f
- 10.1007/BF02806011 · doi:10.1007/bf02806011
- 10.1016/S0091-3057(02)00711-6 · DOI
- 10.1016/S0893-133X(01)00257-3 · DOI · Paper page
- 10.1073/pnas.061369098 · DOI · Paper page
- 10.1007/BF02244882 · DOI
- 10.1007/BF02805972 · DOI · Paper page
- 10.1038/379733a0 · DOI · Paper page
- 10.1073/pnas.93.24.14065 · DOI · Paper page
- 10.1016/S0166-4328(00)00206-0 · DOI · Paper page
- 10.1046/j.1471-4159.1999.0721117.x · DOI · Paper page
- 10.1016/0091-3057(95)02063-2 · DOI
- 10.1016/j.tips.2003.11.003 · DOI · Paper page
- George T P, 2001, Psychiatr Times, 18, 39
- 10.1016/S0006-8993(98)00537-X · DOI · Paper page
- George T P, 2000, J Pharmacol Exp Ther, 295, 58, 10.1016/S0022-3565(24)38869-X · DOI
- 10.1016/S0893-133X(01)00296-2 · DOI · Paper page
- George T P, 2003, Meyer J M
- 10.1007/s002130050554 · DOI
- 10.1093/bmb/65.1.21 · DOI
- 10.1016/S0006-3223(99)00130-4 · DOI · Paper page
- 10.4088/JCP.v59n0503 · DOI
- 10.1212/WNL.52.1.115 · DOI · Paper page
- 10.1093/oxfordjournals.aje.a116960 · DOI · Paper page
- GreenM F, MarshallB D, WirshingW C, AmesD, MarderS R, McGurkS R, KernR S, MintzJ (1997) Does risperidone improve verbal working memory in schizophrenia?' Am J Psychiatry 154: 799-804 · DOI · Paper page
- 10.1007/BF02251289 · DOI · Paper page
- 10.1007/s00213-002-1005-6 · DOI · Paper page
- 10.1046/j.1471-4159.1996.67051953.x · DOI · Paper page
- 10.1016/S0899-3289(20)30005-5 · DOI
- HeishmanS J (1999) Behavioral and cognitive effects of smoking: relationship to nicotine addiction. Nicotine Tobacco Res 1 (Suppl 2): S143–S147 · DOI · Paper page
- HeishmanS J, HenningfieldJ E (2000) Tolernance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers. Psychopharmacology 152: 321-333 · DOI
- 10.1007/s002130050493 · DOI
- HoweM N, PriceI R (2001) Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia. Int Psychogeriatr 13: 465-475 · DOI
- HutchisonK E, NiauraR, SwiftR (2000) The effects of smoking high nicotine cigarettes on pre-pulse inhibition, startle latency, and subjective responses. Psychopharmacology (Berl) 150: 244-252 · DOI
- 10.1146/annurev.pu.10.050189.000555 · DOI
- JonesG M, SahakianB J, LevyR, WarbirtpmD M, GrayJ A (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108: 485-494 · DOI · Paper page
- Kelton M C, 2000, Brain Cognit, 43, 274
- 10.1016/S0306-4603(01)00266-0 · DOI
- KnottV, BosmanM, MahoneyC, IlivitskyV, QuirtK (1999) Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials. Pharmacol Biochem Behav 63: 253-261 · DOI
- 10.1159/000054957 · DOI
- 10.1007/s002130050109 · DOI
- KumariV, GrayJ A (1999) Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berl) 141: 11-15 · DOI
- 10.1007/s002130050360 · DOI
- 10.1001/jama.284.20.2606 · DOI · Paper page
- 10.1016/S0896-6273(02)01004-8 · DOI · Paper page
- 10.1007/BF02244994 · DOI
- 10.1080/14622200110050213 · DOI · Paper page
- 10.1001/archpsyc.59.12.1085 · DOI · Paper page
- 10.1007/BF02247415 · DOI · Paper page
- 10.1007/s002130050667 · DOI · Paper page
- 10.1007/BF02246285 · DOI
- 10.1016/S0893-133X(96)00018-8 · DOI · Paper page
- 10.1007/s002130050750 · DOI · Paper page
- 10.1016/S0926-6410(98)00044-5 · DOI
- 10.1037/1064-1297.9.1.83 · doi:10.1037/1064-1297.9.1.83 · Paper page
- LezakM D (1995) Neuropsychological assessment. Oxford University Press, New York, NY
- 10.1007/s002130051107 · DOI
- 10.1002/neu.10148 · DOI · Paper page
- McConville B J, 1991, Am J Psychiatry, 148, 793, 10.1176/ajp.148.6.793 · DOI
- 10.1016/0006-3223(92)90315-Q · DOI
- 10.1007/s002130100899 · DOI
- 10.1016/S0028-3932(98)00012-8 · DOI
- 10.1007/BF02247425 · DOI
- 10.1038/npp.1994.11 · DOI
- 10.2165/00002512-199711030-00005 · DOI · Paper page
- 10.1007/BF00174504 · DOI · Paper page
- 10.1080/14622299050011371 · DOI
- 10.1038/sj.npp.1300173 · DOI
- 10.1016/S0893-133X(97)00095-X · DOI
- 10.1016/S0165-1781(03)00022-2 · DOI
- 10.1016/S0893-133X(99)00098-6 · DOI
- 10.1124/mol.54.6.1132 · DOI · Paper page
- 10.3109/15622970309167951 · DOI
- ParrottA C, CraigD (1992) Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasks. Neuropsychobiology 25: 34-43 · DOI
- 10.1007/s004150050299 · DOI · Paper page
- 10.1080/1462220021000018425 · DOI · Paper page
- PerkinsK A, GrobeJ E, FonteC, GoettlerJ, CaggiulaA R, ReynoldsW A, StilerR L, ScierkaA, JacobR (1994) Chronic and acute tolerance to subjective, behavioral, and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270:628–638 · DOI · Paper page
- 10.1007/BF00445565 · DOI
- Picciotto M R, 2003, Trends Pharmacol Sci, 23
- 10.1007/s002130050722 · DOI
- 10.1016/0306-4603(94)90058-2 · DOI
- 10.1300/J069v20n01_07 · DOI · Paper page
- 10.1016/0899-3289(95)90030-6 · DOI · Paper page
- 10.1046/j.1360-0443.2002.00117.x · DOI · Paper page
- 10.1007/BF02245662 · DOI
- 10.1017/S0317167100046321 · DOI
- RajputA, OffordK P, BeardC M, KurlandL T (1987) A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology 37: 226-232 · DOI · Paper page
- 10.1523/JNEUROSCI.22-21-09604.2002 · DOI
- 10.1007/s002210000407 · DOI · Paper page
- 10.1002/ana.410190502 · DOI · Paper page
- 10.1016/S0014-2999(02)01452-8 · DOI
- RustedJ M, CaufieldD, KingL, GoodeA (2000) Moving out of the laboratory: does nicotine improve everyday attention?' Behav Pharmacol 11: 621-629 · DOI · Paper page
- SaccoK A, TermineA, SeyalA A, DudasM M, VessicchioJ C, Krishnan-SarinS, JatlowP I, WexlerB E, GeorgeT P (2004) Nicotinic recepter mechanisms and neuropsychological functioning in schizophrenia: effects on spatial working memory and attention. Arch Gen Psychiatry, in press
- SahakianB, JonesG, LevyR, GrayJ, WarburtonD (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154: 797-800 · DOI · Paper page
- SakuraiY, KanazawaI (2002) Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions. Hum Psychopharmacol 17: 369-373 · DOI
- Salin-Pascual R J, 1996, J Clin Psychiatry, 57, 387
- 10.1124/jpet.102.045773 · DOI · Paper page
- 10.1124/jpet.103.051912 · DOI
- 10.1016/S0006-3223(02)01342-2 · DOI
- 10.1007/BF02247722 · DOI
- 10.3109/15622970209150616 · DOI
- SilverA A, ShytleR D, SheehanK H, SheehanD V, RamosA, SanbergP R (2001b) Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. J Am Acad Child Adolesc Psychiatry 40: 1103-1110 · DOI · Paper page
- SimonR (2002) Clinical neurology. McGraw Hill, New York
- 10.1016/S0893-133X(02)00324-X · DOI · Paper page
- Snaedal J J T, 1996, Dementia, 7, 47
- 10.1016/0376-8716(89)90090-2 · DOI
- SpencerT, BiedermanJ (2002) Non-stimulant treatment for attention-deficit/hyperactivity disorder. J Atten Disord 6 (Suppl): S109–S119 · DOI
- SpilichG J (1994) Cognitive benefits of nicotine: fact or fiction? Addiction 89: 141-142 · DOI
- 10.1007/BF02316865 · DOI
- 10.1176/ajp.155.8.1009 · DOI · Paper page
- 10.1007/s002130050573 · DOI · Paper page
- 10.1016/S0014-2999(99)00886-9 · DOI
- Suter T W, 1983, Activas Nervosa Superior, 25, 261
- 10.1177/026988119200600210 · DOI · Paper page
- 10.1016/S0278-5846(01)00194-4 · DOI
- 10.1176/appi.ajp.157.3.368 · DOI · Paper page
- 10.1080/10673220127912 · DOI · Paper page
- Vezina P, 1992, JPET, 261, 484, 10.1016/S0022-3565(25)11064-1 · DOI · Paper page
- VictorM (2001) Adams and Victor's principles of neurology, McGraw Hill, New York
- ViereggeA, SiebererM, JacobsH, HagenahJ M, ViereggeP (2001) Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study. Neurology 57: 1032-1035 · DOI
- 10.1159/000109692 · DOI · Paper page
- 10.1016/0091-3057(91)90109-F · DOI
- 10.1037/0894-4105.14.3.409 · DOI · Paper page
- Weiss M, 2003, Can Med Assoc J, 168, 715
- 10.1007/BF00432014 · DOI
- WestR, HajekP, FouldsJ, NilssonF, MayS, MeadowsA (2000) A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 149: 198-202 · DOI · Paper page
- 10.1007/BF00432045 · DOI
- 10.1007/s002130050931 · DOI · Paper page
- 10.1016/0091-3057(95)00043-V · DOI · Paper page
- Yang Y K, 2002, Neuropsychpharmacology, 27, 684
- ZhaoL, KuoY-P, GeorgeA A, PengJ-H, PurandareM S, SchroederK M, LukasR J, WuJ (2003) Functional properties of homomeric, human alpha-7 nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. J Pharmacol Exp Ther 305: 1132-1141 · DOI
- 10.1177/1073858402239588 · DOI
Cited by
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Self-citationAccounting for Bias Due to Selective Attrition: The Example of Smoking and Cognitive Decline
Weuve, J., Tchetgen Tchetgen, E. J., Glymour, M. M., Beck, T. L., Aggarwal, N. T., Wilson, R. S., Evans, D. A., & Mendes de Leon, C. F. (2012) · Epidemiology · doi:10.1097/ede.0b013e318230e861 · Cited by 514
Interventions for smoking cessation and reduction in individuals with schizophrenia
Tsoi, D. T., Porwal, M., & Webster, A. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007253.pub3 · Cited by 304
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129
“The usefulness of nicotinic treatments for a variety of neuropsychiatric indications including schizophrenia has been suggested [78-82].”
Background
Metadata
- Authors
- Sacco, K. A., Bannon, K. L., & George, T. P.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2004-12
- Volume
- 18
- Issue
- 4
- Pages
- 457-474
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2137395053
- Cited by
- 96
- References
- 30
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. https://app.cochat.ai/papers/10.1177/026988110401800403
- The paper
- Sacco, K. A., Bannon, K. L., & George, T. P. (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology. https://doi.org/10.1177/026988110401800403
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.